CIM
PCRX icon

CIM Investment Management’s Pacira BioSciences PCRX Stock Holding History

CIM Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,685
Closed -$206K – 282
2015
Q4 		$206K Buy
+2,685
New +$152K 0.09% 231
2015
Q2 		– Sell
-2,363
Closed -$210K – 273
2015
Q1 		$210K Buy
+2,363
New +$240K 0.09% 234

Other funds holding PCRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CIM Investment Management's PCRX Position: Q1 2016 in Review

CIM Investment Management sold out of Pacira BioSciences (PCRX) in Q1 2016, closing a stake of 2,685 shares — an estimated $206K sold.

CIM Investment Management first reported a position in PCRX in Q1 2015 and held it in 2 quarters. The position peaked at $210K in Q1 2015. 180 funds tracked by Wall St. Rank hold PCRX as of Q1 2016.

  • CIM Investment Management reported no remaining Pacira BioSciences position as of Q1 2016 after selling out during the quarter.
  • CIM Investment Management sold 2,685 Pacira BioSciences shares in Q1 2016, an estimated $206K.
  • CIM Investment Management first reported a position in Pacira BioSciences in Q1 2015 and held it in 2 quarters.
  • CIM Investment Management's Pacira BioSciences position peaked at $210K in Q1 2015.
  • 180 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2016.

Based on CIM Investment Management's 13F filing for Q1 2016, filed 6 May 2016.